All In Biotech

Drug Trial Radar · NCT01060267

Intravenous Erythromycin Before Endoscopy in Patients With Variceal Bleeding: A Randomized, Double-Blind Trial

Effect of Intravenous Bolus Infusion of Erythromycin Prior to Endoscopy in Patients Presenting With Variceal Bleeding: A Prospective, Randomized, Double- Blind ,Placebo Controlled, Trial

Last checked: Nov 19, 2026Latest source record: Feb 2, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 102 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

102

Actual

Start

Jan 2007

Primary completion

May 2009

Study completion Aug 2009

Sponsor

Lead sponsor
King Abdulaziz Medical CityGovernment (non-federal)
Sponsor type
Government (non-federal)
First posted
Feb 2, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Single group
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Objectives: Blood in stomach \& oesophagus in patients with variceal bleeding often obscures the endoscopic view \& makes endoscopic intervention difficult to perform. Erythromycin, a motilin agonist induces gastric emptying. The aim of this study was to assess the effect of Erythromycin on endoscopic visibility and its outcome.

Conditions

  • Variceal Bleeding

Interventions

  • ErythromycinDrug

    The patients in erythromycin group received intravenous bolus infusion of 125 mg of erythromycin lactobionate in 50 ml of normal saline

  • PlaceboDrug

    patients in placebo group 50ml of normal saline over 10 minutes, 1/2 hour before endoscopy.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The primary end point was to determine the effect of erythromycin on gastric cleansing and thereby quality of endoscopic visualization, reflecting the ease with which the procedure was performed in a clear stomach.Time frame: For upto 45 minutes from start to end of endoscopy

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • King Abdul Aziz Medical City

    Riyadh, Saudi Arabia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.